In a known lymphoma patient with persistent fever and a CBC showing hemoglobin 10 g/dL, RBC count 4.01 ×10⁶/µL, hematocrit 32 %, MCV 80 fL, MCHC 31.15 g/dL, RDW 15.5 %, neutrophils 80 % and lymphocytes 15 %, how should these findings be interpreted and what management steps are recommended?

Management of Persistent Fever in Lymphoma with Neutrophilia and Anemia

In this lymphoma patient with persistent fever, neutrophilia (80%), and normocytic anemia (Hb 10 g/dL, MCV 80 fL), you should continue current empirical broad-spectrum antibiotics without modification if the patient is hemodynamically stable, as persistent fever alone does not warrant antibiotic changes, and focus on identifying the underlying cause through targeted investigations including blood cultures, imaging for occult infection, and assessment for disease progression or hemolysis.

Key CBC Interpretation

Your patient demonstrates several concerning findings:

• Anemia: Hemoglobin 10 g/dL with normocytic indices (MCV 80 fL, borderline low-normal)
• Neutrophilia: 80% neutrophils (4,560/µL absolute count) - significantly elevated
• Relative lymphopenia: 15% lymphocytes (855/µL absolute count) - markedly reduced
• Elevated RDW: 15.5% suggests anisocytosis, which carries prognostic significance in lymphoma 1

The neutrophil-to-lymphocyte ratio (NLR) is approximately 5.3, which is elevated and associated with worse outcomes in lymphoma patients 2.

Fever Management Algorithm

Do NOT modify antibiotics based on fever alone

3 provides clear guidance that persistent fever in a hemodynamically stable patient without new clinical findings is NOT an indication to change or broaden antibiotics. The median time to defervescence in hematologic malignancies is 5 days with empirical antibiotics 3.

Specifically avoid:

• Adding vancomycin empirically for persistent fever (no proven benefit) 3
• Switching between empirical monotherapies without clinical/microbiologic indication 3
• Adding aminoglycosides without documented need for expanded coverage 3

What TO do instead:

1. Continue current broad-spectrum antibiotics if already initiated

2. Obtain directed investigations:

   • Blood cultures (if not already done or if >48 hours since last set)
   • Imaging to identify occult infections (chest CT, abdominal imaging)
   • Evaluate for non-infectious causes

3. Consider non-infectious fever sources 3:

   • Drug-related fever
   • Thrombophlebitis
   • Lymphoma progression (B symptoms)
   • Hemolysis or blood resorption

Anemia Evaluation in Lymphoma Context

The anemia requires specific attention given the lymphoma diagnosis. Multiple mechanisms may be operative 4, 5:

Investigate for:

• Hemolysis: Check reticulocyte count, LDH, indirect bilirubin, haptoglobin

  • Shortened RBC lifespan occurs in 40% of lymphoma patients with anemia 4
  • Cold agglutinins can occur with B-cell lymphomas 6

• Bone marrow involvement: The RDW of 15.5% approaches the prognostic cutoff of 14.45% associated with poorer treatment response in peripheral T-cell lymphoma 1, though this may apply to other lymphoma subtypes

• Splenomegaly: Correlates with both anemia and shortened RBC life 4

• Chemotherapy effects: Aggressive regimens significantly shorten RBC lifespan 4

Prognostic Implications

The elevated NLR (>5) and borderline elevated RDW (15.5%) are independent poor prognostic markers:

• NLR >2.41 predicts complications including venous thromboembolism 2
• RDW ≥14.45% associates with lower overall response rates (41.98% vs 78.75%) and worse prognosis 1

Critical Next Steps

1. If fever persists beyond 5 days: Re-evaluate clinically for new findings, obtain repeat cultures, consider imaging for deep-seated infection

2. If patient deteriorates clinically: Modify antibiotics based on specific clinical/microbiologic findings, not fever pattern alone 3

3. Address anemia: Consider erythropoietin if hemolysis excluded and patient symptomatic 5, though transfusion may be needed if Hb drops further or patient becomes symptomatic

4. Monitor for VTE: The elevated NLR places this patient at increased thrombotic risk 2

Common Pitfalls to Avoid

• Do not reflexively add vancomycin for persistent fever - this is explicitly discouraged 3
• Do not assume neutrophilia means bacterial infection - this may reflect lymphoma-related inflammation or stress response
• Do not ignore the relative lymphopenia - absolute lymphocyte count of 855/µL is low and may reflect disease burden
• Do not overlook cold agglutinins if CBC parameters seem discordant - warm sample to 37°C and retest if suspected 6